The Corporate Reputation of Pharma Companies, 2016: Perspective of 98 Latin-American Patient Groups (2017 Edition) - Research and Markets

DUBLIN--()--The "The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 98 Latin-American Patient Groups (2nd Edition)" report has been added to Research and Markets' offering.

These results are derived from a global review of pharma's corporate reputation (conducted November 2016 to early-February 2017).

This report is based on the opinions of 98 Latin-American patient groups, from Argentina (10), Bolivia (2), Brazil (21), Chile (8), Colombia (8), Costa Rica (6), Cuba (1), the Dominican Republic (1), Ecudaor (2), Guatemala (2), Mexico (27), Panama (1), Peru (2), Uruguay (1), Venezuela (4).

20 specialised in cancer; 9 in neurological conditions; 7 in haemophilia; and other specialties.

15 pharma companies are included in this 2016 Latin-America analysis:

  • AbbVie
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly (Lilly)
  • GSK
  • Janssen (Pharmaceutical companies of Johnson & Johnson)
  • Merck & Co
  • Novartis
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Teva

For more information about this report visit https://www.researchandmarkets.com/research/6qxtw7/the_corporate

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals